EE333 Analysis of the Cost of Managing Patients with Advanced or Metastatic Non-Small Cell Lung Cancer in Argentina: Lorlatinib VS Alectinib
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.578
https://www.valueinhealthjournal.com/article/S1098-3015(22)00779-3/fulltext
Title :
EE333 Analysis of the Cost of Managing Patients with Advanced or Metastatic Non-Small Cell Lung Cancer in Argentina: Lorlatinib VS Alectinib
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00779-3&doi=10.1016/j.jval.2022.04.578
First page :
Section Title :
Open access? :
No
Section Order :
10519